Norges Bank’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Norges Bank’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-557,790	Closed	-$23.5M	–	2053
2023 Q2	$23.5M	Buy	557,790 +14,463	+3%	+$585K	﹤0.01%	1188
2023 Q1	$19.4M	Sell	543,327 -499,560	-48%	-$18.1M	﹤0.01%	1300
2022 Q4	$38.3M	Buy	1,042,887 +240,123	+30%	+$9.49M	0.01%	922
2022 Q3	$37.9M	Buy	802,764 +11,364	+1%	+$734K	0.01%	885
2022 Q2	$56.7M	Sell	791,400 -159,438	-17%	-$11.7M	0.01%	718
2022 Q1	$77M	Sell	950,838 -39,552	-4%	-$3.35M	0.02%	676
2021 Q4	$102M	Buy	990,390 +61,828	+7%	+$5.94M	0.02%	607
2021 Q3	$81.2M	Sell	928,562 -646	-0.1%	-$58.5K	0.02%	701
2021 Q2	$83.2M	Buy	929,208 +94,975	+11%	+$8.02M	0.02%	721
2021 Q1	$63.3M	Buy	834,233 +89,149	+12%	+$6.72M	0.01%	846
2020 Q4	$50.8M	Buy	745,084 +75,794	+11%	+$4.73M	0.01%	964
2020 Q3	$35.6M	Sell	669,290 -50,358	-7%	-$3M	0.01%	1051
2020 Q2	$41.9M	Sell	719,648 -1,263	-0.2%	-$67.9K	0.01%	944
2020 Q1	$28.4M	Sell	720,911 -9,787	-1%	-$572K	0.01%	1025
2019 Q4	$43.5M	Hold	730,698	–	–	0.01%	1009
2019 Q3	$38.9M	Hold	730,698	–	–	0.01%	1028
2019 Q2	$37.3M	Buy	730,698 +35,596	+5%	+$1.66M	0.01%	1070
2019 Q1	$36M	Buy	695,102 +63,584	+10%	+$3.08M	0.01%	1085
2018 Q4	$24.9M	Buy	631,518 +20,842	+3%	+$968K	0.01%	1243
2018 Q3	$31.5M	Buy	610,676 +40,000	+7%	+$1.96M	0.01%	1228
2018 Q2	$26.8M	Sell	570,676 -98,136	-15%	-$4.06M	0.01%	1314
2018 Q1	$23.7M	Buy	668,812 +155,513	+30%	+$6.09M	0.01%	1325
2017 Q4	$22.4M	Buy	513,299 +19,936	+4%	+$931K	0.01%	1414
2017 Q3	$25.8M	Sell	493,363 -59,185	-11%	-$3.3M	0.01%	1277
2017 Q2	$32.3M	Sell	552,548 -7,985	-1%	-$415K	0.01%	1055
2017 Q1	$25.7M	Buy	560,533 +56,867	+11%	+$2.83M	0.01%	1212
2016 Q4	$26.5M	Hold	503,666	–	–	0.01%	1116
2016 Q3	$21.4M	Buy	503,666 +56,206	+13%	+$2.44M	0.01%	1199
2016 Q2	$17.1M	Buy	447,460 +59,000	+15%	+$2.59M	0.01%	1301
2016 Q1	$16M	Buy	388,460 +42,043	+12%	+$1.73M	0.01%	1295
2015 Q4	$16.8M	Buy	346,417 +248,879	+255%	+$11.1M	0.01%	1277
2015 Q3	$3.9M	Buy	97,538 +57,538	+144%	+$2.51M	﹤0.01%	1909
2015 Q2	$1.6M	Buy	+40,000	New	+$1.38M	﹤0.01%	2073

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

CFB

Cullen/Frost Bankers San Antonio, Texas $8.81B AUM 22.47% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Norges Bank's SYNH Position: Q3 2023 in Review

Norges Bank sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 557,790 shares — an estimated $23.5M sold.

Norges Bank first reported a position in SYNH in Q2 2015 and held it in 33 quarters. The position peaked at $102M in Q4 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

Norges Bank reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Norges Bank sold 557,790 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $23.5M.
Norges Bank first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2015 and held it in 33 quarters.
Norges Bank's Syneos Health, Inc. Class A Common Stock position peaked at $102M in Q4 2021.
10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Norges Bank's 13F filing for Q3 2023, filed 13 Nov 2023.